Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)

  • Authors:
    • Meijia Wu
    • Shengwu Huang
  • View Affiliations

  • Published online on: August 28, 2017     https://doi.org/10.3892/mco.2017.1399
  • Pages:738-746
Metrics: PDF 0 views | HTML 0 views
0

Abstract

In recent years, magnetic nanoparticles (MNPs) have demonstrated marked progress in the field of oncology. General nanoparticles are widely used in tumor targeting, and the intrinsic magnetic property of MNPs makes them the most promising nanomaterial to be used as contrast agents for magnetic resonance imaging (MRI) and induced magnetic hyperthermia. The properties of MNPs are fully exploited when they are used as drug delivery agents, wherein drugs may be targeted to the desired specific location in vivo by application of an external magnetic field. Early diagnosis of cancer may be achieved by MRI, therefore, individualized treatment may be combined with MRI, so as to achieve the precise definition and appropriate treatment. In the present review, research on MNPs in cancer diagnosis, drug delivery and treatment has been summarized. Furthermore, the future perspectives and challenges of MNPs in the field of oncology are also discussed.

Related Articles

Journal Cover

November 2017
Volume 7 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wu, M., & Wu, M. (2017). Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review). Molecular and Clinical Oncology, 7, 738-746. https://doi.org/10.3892/mco.2017.1399
MLA
Wu, M., Huang, S."Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)". Molecular and Clinical Oncology 7.5 (2017): 738-746.
Chicago
Wu, M., Huang, S."Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)". Molecular and Clinical Oncology 7, no. 5 (2017): 738-746. https://doi.org/10.3892/mco.2017.1399